To explore the clinic value of trans-vaginal hysterectomy.

From January 2004 to January 2007, 136 hospitalized patients with signs of hysterectomy were divided into trans-vaginal hysterectomy group(TVH group, n= 60)and trans-abdominal hysterectomy group(TAH group, n= 86)according to their choices. Informed consent were obtained from all patients. Sixty cases in the TVH group were all received trans-vaginal hysterectomy, including 43 cases with uterine volume lower than 10 gestational weeks, and 17 cases during 10~14 gestational weeks; and 15 case had operation history. Eighty-six cases in the TAH group were all received trans-abdominal hysterectomy, including 65 cases with uterine volume lower than 10 gestational weeks, and 21 case during 10~14 gestational weeks; and 20 cases had operation history. The following items were compared between two groups, operative duration, blood loss, intraoperative complication, post-surgery anal-exsufflation time, postoperative activity out of bed days, hospitalization time and rate of wound infection.

In terms of the operative duration and intraoperative blood loss, the TVH group were significantly lower than those in the TAH group(t=-5. 11, P<0. 01 ; t=-0. 38, P<0. 05). Furthermore, compared with the items of post-surgery anal-exsufflation time, postoperative activity out of bed days, and wound infection rate, two groups had significant differences(t=-2. 34, P<0. 05; t=-2. 30, P<0. 05; χ²=-2. 30, P<0. 05). There had no significant difference of hospitalization expenses between two groups. All the operations were smoothly completed without any complication.

The trans-vaginal hysterectomy is an applicable minimal invasive operative method, which has better effects than trans-abdominal hysterectomy,